Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin's protection against UV-induced A375-S2 cell apoptosis.

Silymarin, derived from the milk thistle plant, Silybum marianum, has been traditionally used in the treatment of liver disease. Our previous study demonstrated that silymarin has an anti-apoptotic effect against UV irradiation. In this study, SIRT1, a human deacetylase that was reported to promote cell survival, was activated by silymarin (5 x 10(- 4) mol/L) in UV-irradiated human malignant melanoma, A375-S2 cells, followed by down-regulated expression of Bax and decreased release of cytochrome c. Cleavage of procaspase-3 and digestion of its substrates, the inhibitor of caspase-activated DNase (ICAD) and poly(ADP-ribose) polymerase (PARP), were also reduced. Consistent with its protective effect on UV-induced apoptosis, silymarin (5 x 10(- 4) mol/L) also increased G(2)/M phase arrest, possibly providing a prolonged time for efficient DNA repair. Consequently, that silymarin protected A375-S2 cell against UV-induced apoptosis was partially through SIRT1 pathway and modulation of the cell cycle distribution.

Dracorhodin perchlorate induces apoptosis in HL-60 cells.

Dracorhodin perchlorate, an anthocyanin red pigment, induces human premyelocytic leukemia HL-60 cell death through apoptotic pathway. Caspase -1, -3, -8, -9, and -10 inhibitors partially reversed the cell death induced by dracorhodin perchlorate. Caspase-3 and -8 were activated followed to the degradation of caspase-3 substrates, inhibitor of caspase-activated DNase (ICAD) and poly-(ADP-ribose) polymerase (PARP). Dracorhodin perchlorate up-regulated the expression ratio of mitochondrial proteins, Bax/Bcl-XL. The cell death was accompanied with phosphorylation of ERK, JNK and p38 MAPK and partially reduced by MEK inhibitor (PD98059), JNK MAPK inhibitor (SP600125) and p38 MAPK inhibitor (SB 203580). Taken together, dracorhodin perchlorate-induced apoptosis in HL-60 cells via up-regulation of Bax, activation of caspases and ERK/p38/JNK MAPKs.

Candida lipolytica mutants defective in an acyl-coenzyme A synthetase: isolation and fatty acid metabolism.

Mutant strains of Candida lipolytica defective in an acyl-CoA synthetase [acid:CoA ligase (AMP-forming); EC 6.2.1.3]were isolated. The mutant strains apparently exhibited no acyl-CoA synthetase activity in vitro and were, in contrast to the wild-type strain, incapable of growing in the presence of exogenous fatty acid when cellular synthesis de novo of fatty acid was blocked. However, the mutant strains grew on either fatty acid or n-alkane as a sole carbon source at rates comparable to that observed for the wild-type strain. Analysis of the fatty acid composition of the lipids from the mutant cells grown on odd-chain-length fatty acid as well as [14C]oleic acid incorporation studies have shown that the mutant cells, unlike the wild-type cells, cannot incorporate exogenous fatty acid as a whole into cellular lipids, but utilize the fatty acid that is synthesized de novo from acetyl-CoA produced by degradation of exogenous fatty acid. This finding indicates the presence of at least two acyl-CoA synthetases that activate long-chain fatty acid. One, designated acyl-CoA synthetase I, which is absent in the mutant strains, is responsible for the production of acyl-CoA to be utilized for the synthesis of cellular lipids. The other acyl-CoA synthetase provides actyl-CoA that is exclusively degraded via beta-oxidation to yield acetyl-CoA.